Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Immunotherapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Cytokine-Based Immunotherapy
1.2.4 Cancer Vaccines
1.2.5 CAR-T Cell Therapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Oncology Immunotherapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Immunotherapy Market Perspective (2018-2029)
2.2 Oncology Immunotherapy Growth Trends by Region
2.2.1 Global Oncology Immunotherapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oncology Immunotherapy Historic Market Size by Region (2018-2024)
2.2.3 Oncology Immunotherapy Forecasted Market Size by Region (2024-2029)
2.3 Oncology Immunotherapy Market Dynamics
2.3.1 Oncology Immunotherapy Industry Trends
2.3.2 Oncology Immunotherapy Market Drivers
2.3.3 Oncology Immunotherapy Market Challenges
2.3.4 Oncology Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Immunotherapy Players by Revenue
3.1.1 Global Top Oncology Immunotherapy Players by Revenue (2018-2024)
3.1.2 Global Oncology Immunotherapy Revenue Market Share by Players (2018-2024)
3.2 Global Oncology Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Immunotherapy Revenue
3.4 Global Oncology Immunotherapy Market Concentration Ratio
3.4.1 Global Oncology Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Immunotherapy Revenue in 2022
3.5 Oncology Immunotherapy Key Players Head office and Area Served
3.6 Key Players Oncology Immunotherapy Product Solution and Service
3.7 Date of Enter into Oncology Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Immunotherapy Breakdown Data by Type
4.1 Global Oncology Immunotherapy Historic Market Size by Type (2018-2024)
4.2 Global Oncology Immunotherapy Forecasted Market Size by Type (2024-2029)
5 Oncology Immunotherapy Breakdown Data by Application
5.1 Global Oncology Immunotherapy Historic Market Size by Application (2018-2024)
5.2 Global Oncology Immunotherapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oncology Immunotherapy Market Size (2018-2029)
6.2 North America Oncology Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oncology Immunotherapy Market Size by Country (2018-2024)
6.4 North America Oncology Immunotherapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Immunotherapy Market Size (2018-2029)
7.2 Europe Oncology Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oncology Immunotherapy Market Size by Country (2018-2024)
7.4 Europe Oncology Immunotherapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Immunotherapy Market Size (2018-2029)
8.2 Asia-Pacific Oncology Immunotherapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oncology Immunotherapy Market Size by Region (2018-2024)
8.4 Asia-Pacific Oncology Immunotherapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Immunotherapy Market Size (2018-2029)
9.2 Latin America Oncology Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oncology Immunotherapy Market Size by Country (2018-2024)
9.4 Latin America Oncology Immunotherapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Immunotherapy Market Size (2018-2029)
10.2 Middle East & Africa Oncology Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oncology Immunotherapy Market Size by Country (2018-2024)
10.4 Middle East & Africa Oncology Immunotherapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Detail
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Oncology Immunotherapy Introduction
11.1.4 Bristol-Myers Squibb Revenue in Oncology Immunotherapy Business (2018-2024)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Detail
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Oncology Immunotherapy Introduction
11.2.4 Merck & Co Revenue in Oncology Immunotherapy Business (2018-2024)
11.2.5 Merck & Co Recent Development
11.3 Roche AG
11.3.1 Roche AG Company Detail
11.3.2 Roche AG Business Overview
11.3.3 Roche AG Oncology Immunotherapy Introduction
11.3.4 Roche AG Revenue in Oncology Immunotherapy Business (2018-2024)
11.3.5 Roche AG Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Oncology Immunotherapy Introduction
11.4.4 AstraZeneca Revenue in Oncology Immunotherapy Business (2018-2024)
11.4.5 AstraZeneca Recent Development
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Detail
11.5.2 Sanofi S.A. Business Overview
11.5.3 Sanofi S.A. Oncology Immunotherapy Introduction
11.5.4 Sanofi S.A. Revenue in Oncology Immunotherapy Business (2018-2024)
11.5.5 Sanofi S.A. Recent Development
11.6 Dendreon Pharmaceuticals
11.6.1 Dendreon Pharmaceuticals Company Detail
11.6.2 Dendreon Pharmaceuticals Business Overview
11.6.3 Dendreon Pharmaceuticals Oncology Immunotherapy Introduction
11.6.4 Dendreon Pharmaceuticals Revenue in Oncology Immunotherapy Business (2018-2024)
11.6.5 Dendreon Pharmaceuticals Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Oncology Immunotherapy Introduction
11.7.4 Novartis Revenue in Oncology Immunotherapy Business (2018-2024)
11.7.5 Novartis Recent Development
11.8 Gilead Sciences Inc.
11.8.1 Gilead Sciences Inc. Company Detail
11.8.2 Gilead Sciences Inc. Business Overview
11.8.3 Gilead Sciences Inc. Oncology Immunotherapy Introduction
11.8.4 Gilead Sciences Inc. Revenue in Oncology Immunotherapy Business (2018-2024)
11.8.5 Gilead Sciences Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Detail
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Oncology Immunotherapy Introduction
11.9.4 Merck KGaA Revenue in Oncology Immunotherapy Business (2018-2024)
11.9.5 Merck KGaA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oncology Immunotherapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Immune Checkpoint Inhibitors
Table 3. Key Players of Cytokine-Based Immunotherapy
Table 4. Key Players of Cancer Vaccines
Table 5. Key Players of CAR-T Cell Therapy
Table 6. Key Players of Other
Table 7. Global Oncology Immunotherapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Oncology Immunotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Oncology Immunotherapy Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Oncology Immunotherapy Market Share by Region (2018-2024)
Table 11. Global Oncology Immunotherapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Oncology Immunotherapy Market Share by Region (2024-2029)
Table 13. Oncology Immunotherapy Market Trends
Table 14. Oncology Immunotherapy Market Drivers
Table 15. Oncology Immunotherapy Market Challenges
Table 16. Oncology Immunotherapy Market Restraints
Table 17. Global Oncology Immunotherapy Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Oncology Immunotherapy Market Share by Players (2018-2024)
Table 19. Global Top Oncology Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Immunotherapy as of 2022)
Table 20. Ranking of Global Top Oncology Immunotherapy Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Oncology Immunotherapy Revenue (CR5 and HHI) & (2018-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncology Immunotherapy Product Solution and Service
Table 24. Date of Enter into Oncology Immunotherapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Immunotherapy Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Oncology Immunotherapy Revenue Market Share by Type (2018-2024)
Table 28. Global Oncology Immunotherapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Oncology Immunotherapy Revenue Market Share by Type (2024-2029)
Table 30. Global Oncology Immunotherapy Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Oncology Immunotherapy Revenue Market Share by Application (2018-2024)
Table 32. Global Oncology Immunotherapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Oncology Immunotherapy Revenue Market Share by Application (2024-2029)
Table 34. North America Oncology Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Oncology Immunotherapy Market Size by Country (2018-2024) & (US$ Million)
Table 36. North America Oncology Immunotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Oncology Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Oncology Immunotherapy Market Size by Country (2018-2024) & (US$ Million)
Table 39. Europe Oncology Immunotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Oncology Immunotherapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Oncology Immunotherapy Market Size by Region (2018-2024) & (US$ Million)
Table 42. Asia-Pacific Oncology Immunotherapy Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Oncology Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Oncology Immunotherapy Market Size by Country (2018-2024) & (US$ Million)
Table 45. Latin America Oncology Immunotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Oncology Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Oncology Immunotherapy Market Size by Country (2018-2024) & (US$ Million)
Table 48. Middle East & Africa Oncology Immunotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 49. Bristol-Myers Squibb Company Detail
Table 50. Bristol-Myers Squibb Business Overview
Table 51. Bristol-Myers Squibb Oncology Immunotherapy Product
Table 52. Bristol-Myers Squibb Revenue in Oncology Immunotherapy Business (2018-2024) & (US$ Million)
Table 53. Bristol-Myers Squibb Recent Development
Table 54. Merck & Co Company Detail
Table 55. Merck & Co Business Overview
Table 56. Merck & Co Oncology Immunotherapy Product
Table 57. Merck & Co Revenue in Oncology Immunotherapy Business (2018-2024) & (US$ Million)
Table 58. Merck & Co Recent Development
Table 59. Roche AG Company Detail
Table 60. Roche AG Business Overview
Table 61. Roche AG Oncology Immunotherapy Product
Table 62. Roche AG Revenue in Oncology Immunotherapy Business (2018-2024) & (US$ Million)
Table 63. Roche AG Recent Development
Table 64. AstraZeneca Company Detail
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Oncology Immunotherapy Product
Table 67. AstraZeneca Revenue in Oncology Immunotherapy Business (2018-2024) & (US$ Million)
Table 68. AstraZeneca Recent Development
Table 69. Sanofi S.A. Company Detail
Table 70. Sanofi S.A. Business Overview
Table 71. Sanofi S.A. Oncology Immunotherapy Product
Table 72. Sanofi S.A. Revenue in Oncology Immunotherapy Business (2018-2024) & (US$ Million)
Table 73. Sanofi S.A. Recent Development
Table 74. Dendreon Pharmaceuticals Company Detail
Table 75. Dendreon Pharmaceuticals Business Overview
Table 76. Dendreon Pharmaceuticals Oncology Immunotherapy Product
Table 77. Dendreon Pharmaceuticals Revenue in Oncology Immunotherapy Business (2018-2024) & (US$ Million)
Table 78. Dendreon Pharmaceuticals Recent Development
Table 79. Novartis Company Detail
Table 80. Novartis Business Overview
Table 81. Novartis Oncology Immunotherapy Product
Table 82. Novartis Revenue in Oncology Immunotherapy Business (2018-2024) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Gilead Sciences Inc. Company Detail
Table 85. Gilead Sciences Inc. Business Overview
Table 86. Gilead Sciences Inc. Oncology Immunotherapy Product
Table 87. Gilead Sciences Inc. Revenue in Oncology Immunotherapy Business (2018-2024) & (US$ Million)
Table 88. Gilead Sciences Inc. Recent Development
Table 89. Merck KGaA Company Detail
Table 90. Merck KGaA Business Overview
Table 91. Merck KGaA Oncology Immunotherapy Product
Table 92. Merck KGaA Revenue in Oncology Immunotherapy Business (2018-2024) & (US$ Million)
Table 93. Merck KGaA Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Immunotherapy Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Oncology Immunotherapy Market Share by Type: 2022 VS 2029
Figure 3. Immune Checkpoint Inhibitors Features
Figure 4. Cytokine-Based Immunotherapy Features
Figure 5. Cancer Vaccines Features
Figure 6. CAR-T Cell Therapy Features
Figure 7. Other Features
Figure 8. Global Oncology Immunotherapy Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Oncology Immunotherapy Market Share by Application: 2022 VS 2029
Figure 10. Hospitals Case Studies
Figure 11. Drugstores Case Studies
Figure 12. Others Case Studies
Figure 13. Oncology Immunotherapy Report Years Considered
Figure 14. Global Oncology Immunotherapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Oncology Immunotherapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Oncology Immunotherapy Market Share by Region: 2022 VS 2029
Figure 17. Global Oncology Immunotherapy Market Share by Players in 2022
Figure 18. Global Top Oncology Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Immunotherapy as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Oncology Immunotherapy Revenue in 2022
Figure 20. North America Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Oncology Immunotherapy Market Share by Country (2018-2029)
Figure 22. United States Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Oncology Immunotherapy Market Share by Country (2018-2029)
Figure 26. Germany Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Oncology Immunotherapy Market Share by Region (2018-2029)
Figure 34. China Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Oncology Immunotherapy Market Share by Country (2018-2029)
Figure 42. Mexico Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Oncology Immunotherapy Market Share by Country (2018-2029)
Figure 46. Turkey Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Oncology Immunotherapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Oncology Immunotherapy Business (2018-2024)
Figure 49. Merck & Co Revenue Growth Rate in Oncology Immunotherapy Business (2018-2024)
Figure 50. Roche AG Revenue Growth Rate in Oncology Immunotherapy Business (2018-2024)
Figure 51. AstraZeneca Revenue Growth Rate in Oncology Immunotherapy Business (2018-2024)
Figure 52. Sanofi S.A. Revenue Growth Rate in Oncology Immunotherapy Business (2018-2024)
Figure 53. Dendreon Pharmaceuticals Revenue Growth Rate in Oncology Immunotherapy Business (2018-2024)
Figure 54. Novartis Revenue Growth Rate in Oncology Immunotherapy Business (2018-2024)
Figure 55. Gilead Sciences Inc. Revenue Growth Rate in Oncology Immunotherapy Business (2018-2024)
Figure 56. Merck KGaA Revenue Growth Rate in Oncology Immunotherapy Business (2018-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed